Date Title Statement Presentation Report Webcast
9 March 2018

2018 AGM notice

Statement      
9 March 2018

Annual report 2017

    Report  
13 February 2018

Investor presentation

  Presentation    
7 September 2017

Top-Line Data from Phase 2a Clinical Trial in COPD with RPL554 Dosed in Addition to Tiotropium (Spiriva®)

  Presentation    
14 August 2017

Investor presentation, August 2017

  Presentation    
20 March 2017

2017 AGM Notice

Statement      
27 February 2017

Annual report 2016

    Report  
18 January 2017

Shareholder Circular for consolidation, authority to issue new shares, adoption of new Articles and Notice of Meeting on 8 February 2017

Statement      
18 January 2017

Proposed new Articles for adoption at Meeting on 8 February 2017

Statement      
12 September 2016

Interim report 2016

    Report  
Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us